DOI 10.1016/j.bmcl.2026.130714
New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.
Аннотация
Candida albicans infections are becoming increasingly prevalent, making the development of new drugs an urgent priority. In this study, a series of new aminopiperidine-azole derivatives were designed, synthesized, and evaluated for their in vitro antifungal activity against both FLC-sensitive and -resistant strains of C. albicans. Several compounds exhibited good antifungal activity, with compound 5p demonstrating the most promising efficacy against the sensitive strain SC5314 (MIC50 = 0.28 μM). Mechanism studies revealed that 5p significantly inhibited biofilm formation and hyphal growth by downregulating key genes of the cAMP-PKA signaling pathway, including RAS1, EFG1, BCR1, ECE1, and HWP1. Furthermore, 5p showed low cytotoxicity against human bronchial epithelial cells (16HBE) at effective concentrations. These findings suggest that 5p is a promising lead compound for the development of new antifungal drugs.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.